V M Asensio-Sánchez
Research Subjects
Research Interests
V M Asensio-Sánchez has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
B. Rodríguez-Delgado
6 shared publicationsC. García-Loygorri
6 shared publicationsE. García-Herrero
6 shared publicationsV. Cabo-Vaquera
6 shared publicationsR Rodríguez
5 shared publicationsS Martínez-Calvo
5 shared publications
Latest Publications
- Open Access
- 1 June 2009
- Published by Elsevier in Archivos de la Sociedad Española de Oftalmología
- Vol. 84 (6) , 281
Lentes intraoculares amarillas
- 1 June 2009
- Published by Elsevier in Archivos de la Sociedad Española de Oftalmología
- Vol. 84 (6) , 281
Open AccessLentes intraoculares amarillas
- 1 March 2008
- Vol. 83 (3) , 169-72
[Erythropoietin concentrations in the vitreous body from patients with proliferative diabetic retinopathy].
To measure erythropoietin (Epo) levels in the vitreous body from patients with proliferative diabetic retinopathy (PDR). Undiluted vitreous samples were obtained from 44 patients who had not undergone prior vitreous or intraocular surgery. Patients were divided into two groups: A (n= 24) patients with PDR and B (n= 20) patients with retinal detachment, preretinal macular membranes and macular holes. Epo was determined using radioimmunoassay. Epo vitreous concentration in group A was 512 mU/mL (range 120-880) and in group B was 25.1 mU/mL (range 5.2-201) (p< 0.001). These results show that the concentration of Epo in the vitreous body was significantly higher in patients with PDR than in the control group.
- 1 March 2008
- Vol. 83 (3) , 169-72
[Erythropoietin concentrations in the vitreous body from patients with proliferative diabetic retinopathy].
To measure erythropoietin (Epo) levels in the vitreous body from patients with proliferative diabetic retinopathy (PDR). Undiluted vitreous samples were obtained from 44 patients who had not undergone prior vitreous or intraocular surgery. Patients were divided into two groups: A (n= 24) patients with PDR and B (n= 20) patients with retinal detachment, preretinal macular membranes and macular holes. Epo was determined using radioimmunoassay. Epo vitreous concentration in group A was 512 mU/mL (range 120-880) and in group B was 25.1 mU/mL (range 5.2-201) (p< 0.001). These results show that the concentration of Epo in the vitreous body was significantly higher in patients with PDR than in the control group.
- 1 March 2008
- Vol. 83 (3) , 173-6
[Clinically significant diabetic macular edema: systemic risk factors].
We examined the influence of non-ophthalmic parameters as risk factors of clinically significant macular edema (CSME). The authors reviewed clinical records of all clinically significant macular edema between 1995 and 2005. The association between the presence of CSME and HgbA1c, onset and duration of diabetes, blood pressure, body mass index, lipid status, sex, tobacco smoking and urinary albumin excretion was evaluated. 208 eyes met the study criteria. Patients ranged in age from 14 to 82 years (mean, 66 years) and had 8 to 64 years (mean, 47.5 years) of history of diabetes. Significant risk factors for CSME were older age, high levels of HgbA1c, high values of blood pressure, tobacco smoking, high cholesterol and LDL-cholesterol and high levels of proteinuria and microalbuminuria. Independent on the type of diabetes, patients with long standing diabetes have a high risk to develop diabetic maculopathy, but other closely-related risk factors are hypertension, hyperglycemia, lipids, tobacco smoking and renal status.
- 1 March 2008
- Vol. 83 (3) , 173-6
[Clinically significant diabetic macular edema: systemic risk factors].
We examined the influence of non-ophthalmic parameters as risk factors of clinically significant macular edema (CSME). The authors reviewed clinical records of all clinically significant macular edema between 1995 and 2005. The association between the presence of CSME and HgbA1c, onset and duration of diabetes, blood pressure, body mass index, lipid status, sex, tobacco smoking and urinary albumin excretion was evaluated. 208 eyes met the study criteria. Patients ranged in age from 14 to 82 years (mean, 66 years) and had 8 to 64 years (mean, 47.5 years) of history of diabetes. Significant risk factors for CSME were older age, high levels of HgbA1c, high values of blood pressure, tobacco smoking, high cholesterol and LDL-cholesterol and high levels of proteinuria and microalbuminuria. Independent on the type of diabetes, patients with long standing diabetes have a high risk to develop diabetic maculopathy, but other closely-related risk factors are hypertension, hyperglycemia, lipids, tobacco smoking and renal status.
- 1 March 2008
- Vol. 83 (3) , 177-82
[Central serous chorioretinopathy as an extradigestive manifestation of Helicobacter pylori gastric infection].
Helicobacter pylori (HP) gastric infection has been implicated as an important factor in occlusive arterial pathology. Nowadays, it is suspected that central serous chorioretinopathy (CSC) is due to a multifocal vascular occlusive disease of the choriocapillaris. The aim of this study was to determine the relation between gastric HP infection and CSC. We evaluated a group of 16 patients with CSC and 20 controls. HP infection was assessed by the 13C-urea breath test (UBT). Clinical CSC diagnosis was confirmed by fundus biomicroscopy and fluorescein angiography. Out of 16 patients with CSC, 11 (68.75%) were males and 5 (31.25%) females, with a mean age of 46.3 years. HP infection was positive in 11 patients (68.75%) and negative in 5 (31.25%). Men were HP-positive (HP+) in 72.7% of cases, compared to women who were HP+ in 60% of cases. The difference in prevalence of HP between the CSC-group (68.75%) and the control-group (30%) was found to be statistically significant (p< 0.05). HP+ patients had more gastric pain than HP negative (HP-) patients (72.73% vs 20%). These results indicate a possible statistical association between Helicobacter pylori gastric infection and CSC. HP should thus be considered a risk factor in CSC patients.
- 1 March 2008
- Vol. 83 (3) , 177-82
[Central serous chorioretinopathy as an extradigestive manifestation of Helicobacter pylori gastric infection].
Helicobacter pylori (HP) gastric infection has been implicated as an important factor in occlusive arterial pathology. Nowadays, it is suspected that central serous chorioretinopathy (CSC) is due to a multifocal vascular occlusive disease of the choriocapillaris. The aim of this study was to determine the relation between gastric HP infection and CSC. We evaluated a group of 16 patients with CSC and 20 controls. HP infection was assessed by the 13C-urea breath test (UBT). Clinical CSC diagnosis was confirmed by fundus biomicroscopy and fluorescein angiography. Out of 16 patients with CSC, 11 (68.75%) were males and 5 (31.25%) females, with a mean age of 46.3 years. HP infection was positive in 11 patients (68.75%) and negative in 5 (31.25%). Men were HP-positive (HP+) in 72.7% of cases, compared to women who were HP+ in 60% of cases. The difference in prevalence of HP between the CSC-group (68.75%) and the control-group (30%) was found to be statistically significant (p< 0.05). HP+ patients had more gastric pain than HP negative (HP-) patients (72.73% vs 20%). These results indicate a possible statistical association between Helicobacter pylori gastric infection and CSC. HP should thus be considered a risk factor in CSC patients.
- Open Access
- 1 March 2008
- Published by Elsevier in Archivos de la Sociedad Española de Oftalmología
- Vol. 83 (3) , 177-182
Coriorretinopatía serosa central como manifestación extradigestiva de infección gástrica por helicobacter pylori
- 1 March 2008
- Published by Elsevier in Archivos de la Sociedad Española de Oftalmología
- Vol. 83 (3) , 177-182
Open AccessCoriorretinopatía serosa central como manifestación extradigestiva de infección gástrica por helicobacter pylori
- Open Access
- 1 March 2008
- Published by Elsevier in Archivos de la Sociedad Española de Oftalmología
- Vol. 83 (3) , 173-176
Edema macular diabético clínicamente significativo: factores sistémicos de riesgo
- 1 March 2008
- Published by Elsevier in Archivos de la Sociedad Española de Oftalmología
- Vol. 83 (3) , 173-176
Open AccessEdema macular diabético clínicamente significativo: factores sistémicos de riesgo
- Open Access
- 1 March 2008
- Published by Elsevier in Archivos de la Sociedad Española de Oftalmología
- Vol. 83 (3) , 169-172
Concentración de eritropoyetina en el vítreo de pacientes con retinopatía diabética proliferante
- 1 March 2008
- Published by Elsevier in Archivos de la Sociedad Española de Oftalmología
- Vol. 83 (3) , 169-172
Open AccessConcentración de eritropoyetina en el vítreo de pacientes con retinopatía diabética proliferante
- Open Access
- 1 February 2008
- Published by Elsevier in Archivos de la Sociedad Española de Oftalmología
- Vol. 83 (2) , 85-88
Microalbuminuria y retinopatía diabética
- 1 February 2008
- Published by Elsevier in Archivos de la Sociedad Española de Oftalmología
- Vol. 83 (2) , 85-88
Open AccessMicroalbuminuria y retinopatía diabética
- Open Access
- 1 December 2007
- Published by Elsevier in Archivos de la Sociedad Española de Oftalmología
- Vol. 82 (12) , 753-756
HLA-A24: factor de riesgo en retinopatía diabética proliferante
- 1 December 2007
- Published by Elsevier in Archivos de la Sociedad Española de Oftalmología
- Vol. 82 (12) , 753-756
Open AccessHLA-A24: factor de riesgo en retinopatía diabética proliferante
- Open Access
- 1 May 2007
- Published by Elsevier in Archivos de la Sociedad Española de Oftalmología
- Vol. 82 (5) , 299-302
Alucinaciones visuales secundarias al tratamiento con ciprofloxacino
- 1 May 2007
- Published by Elsevier in Archivos de la Sociedad Española de Oftalmología
- Vol. 82 (5) , 299-302
Open AccessAlucinaciones visuales secundarias al tratamiento con ciprofloxacino